EGFR Gene AmplificationNCIt concept

https://www.inrs.fr/media.html?refINRS=TF%20315
2024
France
journal article
Gene Amplification Positive
Tiredness Visual Analogue Scale
Sector
Alcohol Use Disorder Identification Test Self-Report Version Questionnaire
Audit Object
fatigue
Enhancer
Amplifier Device
audition, nos
Fatigue
Hearing
risk
Auditory
Bothered by Tiredness
Audit
Fatigue Subordinate Domain
hearing
amplifiers, electronic
ear, nos
music
EGFR Gene Amplification
auditory fatigue

---
https://pepite-depot.univ-lille.fr/RESTREINT/Th_Medecine/2023/2023ULILM132.pdf
2023
France
dissertations, academic
Additional Surgery for New Tumor Event Present
Adjuvant Post-operative Immunological Therapy Was Administered
KIT Mutation Analysis Was Performed
Any Metastatic Diagnosis Present
NF1 Mutation Analysis Was Performed
Cancer History Present
IDH Gene Family Mutation
Adjuvant Post-operative Radiation Therapy Was Administered
Adjuvant Post-operative Targeted Molecular Therapy Was Administered
Chief Complaint Caused by Trauma
Adjuvant Post-operative Chemotherapy Was Administered
ATRX Gene Mutation
Interferon Gamma Treatment was Administered Prior to Specimen Resection
Patient was Previously Evaluated for Current Chief Complaint
Minor Criteria for Rheumatic Heart Disease Present
Adjuvant I-131 Therapy Positive
Use of Smokeless Tobacco at Time of Diagnosis Positive
Intervention Given for Kawasaki Disease
Immunotherapy Was Administered as an Additional Treatment for a New Tumor Event
Documentation Present
History of Colorectal Cancer Positive
Has Sibling
Adjuvant Post-operative Pharmaceutical Therapy Was Administered
Family History of Stomach Cancer Present
Interferon Gamma Treatment was Administered 90 Days Prior to Specimen Resection
EGFR Mutation Analysis Was Performed
Intercurrent Illness is Present at Onset of Chief Complaint
Preoperative IV Opiates were Administered
ROS1 Rearrangement Analysis Was Performed
Hormone Therapy Was Administered as an Additional Treatment for a New Tumor Event
Has Response to Intervention for Kawasaki Disease
First Degree Family History of Primary Brain Tumor Positive
Radiation Was Administered as an Additional Treatment for a New Tumor Event
Medication Taken
Trial Phase
spirituality
KRAS Mutation Analysis Was Performed
Known History of Congenital Heart Disease
Hypertension Present
Tumor Progression Present After Initial Treatment
Lymph Node Dissection Was Performed
Therapeutic Ionizing Radiation to Head History Present
Peripheral Blood Immunophenotyping and Cytochemistry Were Performed
First Degree Family History Thyroid Cancer Positive
Lost To Follow-Up
Speak
EGFR Gene Amplification
PTEN Gene Mutation
IDH Family Mutation Analysis Was Performed
Radiation History Positive
Preoperative IV Sedation was Administered
Chemotherapy Was Administered as an Additional Treatment for a New Tumor Event
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Performed
RET Rearrangement Analysis Was Performed
Preoperative IV Antacids were Administered
MET Mutation Analysis Was Performed
New Disease is Multifocal
Chemotherapy Received
ERBB2 Mutation Analysis Was Performed
History of Medical Treatment Present
Multiple Known Primary Tumors Present at Initial Melanoma Diagnosis
Patient was Postmenopausal with no Prior Oophorectomy
PDGFRA Mutation Analysis Was Performed
First Degree Family History Cancer Positive
Additional Surgery for New Loco-Regional Tumor Event Was Performed
Known History of Gestational Complication
Fluorescence In Situ Hybridization Was Performed
10q23/PTEN Locus Deletion Analysis Was Performed
Additional Molecular Studies Were Performed
Another Form of Birth Control was Used
EGFR Amplification Analysis Was Performed
Known History of Rheumatic Fever
Other Preoperative IV Medications were Administered
Physician Diagnosed Diabetes Present
Routine Cytogenetics Were Completed
ALK Rearrangement Analysis Was Performed
NRAS Mutation Analysis Was Performed
Tumor Reoccurrence Present After Initial Treatment
Evidence of Disease Present after Completion of Therapy
Chemical/Occupational Exposure Present
BRAF Rearrangement Analysis Was Performed
Regular Smokeless Tobacco Use for Six Weeks or More Positive
Preoperative IV Antiemetics were Administered
Additional Surgery for New Metastatic Tumor Event Was Performed
BRAF Mutation Analysis Was Performed
Regional Anesthesia was Administered
1p/19q Deletion Analysis Was Performed
What Month is it
IV Anesthesia was Administered
YES1 wt Allele
Targeted Molecular Therapy Was Administered as an Additional Treatment for a New Tumor Event
ATRX Mutation Analysis Was Performed
Known History of Illicit Drug Use
New Tumor Event After Initial Treatment Present
SDH Complex Mutation Analysis Was Performed
Known History of Kawasaki Disease
PTEN Mutation Analysis Was Performed
TP53 Mutation Analysis Was Performed
Subsequent Known Primary Melanoma(s) Found During the Follow-Up
Known History of Neonatal Complication
Local Anesthesia Agents were Administered
Additional Immunohistochemistry Was Performed
Participant Exposed to Secondhand Smoke
Known History of Alcohol Use
MGMT Promoter Methylation Testing Was Performed

---